PARP1, BRCA1 and androgen receptor expression in triple-negative breast cancer patients treated with neoadjuvant chemotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

PARP1, BRCA1 and androgen receptor expression in triple-negative breast cancer patients treated with neoadjuvant chemotherapy

Published:2022-10 Issue:4 Volume:35 Page:228-235
ISSN:0214-1582
Container-title:Revista de Senología y Patología Mamaria
language:en
Short-container-title:Revista de Senología y Patología Mamaria

Author:

Rashed Hayam E.,Monged Randa E.,Nawar Nashwa,Alattar Ahmed Z.,Alnagar Ahmed A.,Abdelhamid Mohamed I.,Abdelaziz Osama,Said Nelly M.

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Obstetrics and Gynecology,Surgery

Reference30 articles.

1. Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy;Farmer;Nature,2005

2. New insights into the molecular and cellular functions of poly(ADP-ribose) and PARPs;Gibson;Nat Rev Mol Cell Biol.,2012

3. Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer;Haffty;J Clin Oncol.,2006

4. Triple-negative breast cancer: clinical features and patterns of recurrence;Dent;Clin Cancer Res.,2007

5. Androgen receptor expression in breast cancer patients tested for BRCA1 and BRCA2 mutations;Pristauz;Histopathology.,2010

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A comparative study of Bazedoxifene, Exemestane, Fulvestrant, Raloxifene, Tryprostatin A, and Vorinostat compounds as potential inhibitors against breast cancer through molecular docking, and molecular dynamics simulation;Chinese Journal of Analytical Chemistry;2023-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP